Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.
Nettis
E
E
Dambra
P
P
D'Oronzio
L
L
Loria
M P
MP
Ferrannini
A
A
Tursi
A
A
D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003521:Cyclopropanes; D004311:Double-Blind Method; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D016593:Terfenadine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy*
D000085:Acetates; D003521:Cyclopropanes; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D016593:Terfenadine; C093230:fexofenadine; C093875:montelukast